Visalytics
Visalytics
approved EB-2 (NIW)

Scientist

Organic Chemistry · Hong Kong · 2022-04-23

Processing Time
80 days
Decision Date
2022-04-23
Location
Massachusetts
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue research on developing and improving oncology and neurology drugs and treatment methods. The work focuses on validating new therapeutic targets and developing molecular treatments for prominent diseases, including cancer, to improve global public health outcomes.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research on oncology and neurology drugs was found to be of immense value and clear national importance to the United States.

2 Well-positioned to Advance the Endeavor Met

The petitioner's 7 years of experience, publication record, and 92 citations demonstrated he is well-positioned to continue his research.

3 Waiver of Job Offer and Labor Certification Met

On balance, it was determined beneficial to the U.S. to waive the requirements due to the significance of the petitioner's contributions to public health.

Why This Petition Was Approved

The petition was approved based on 4 first-authored peer-reviewed journal articles and 92 citations. Additional evidence included 5 peer-review assignments, 1 patent in preparation, 7 years of research experience, and funding from 4 national and international institutions. Two expert recommendation letters and 4 detailed project descriptions satisfied the Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Patents
Reference Letters Dependent
Grants
Judging Experience
Original Contributions

Similar Cases

Postdoctoral Researcher

Research and Development · India

WeGreened EB-2 (NIW) approved
New York 6 days 2023-09-17
The petitioner proposes to continue his work in organic chemistry, specifically focusing on the design and synthesis of disease-specific small-molecule drugs. His research aims to develop better, cheaper, and more effective methods and materials for treating glioblastoma and other neurological disorders. This work is intended to alleviate the rising burden of nervous system cancers on the U.S. healthcare system.
View Case

Postdoctoral Researcher

Pharmaceuticals · Bangladesh

WeGreened EB-2 (NIW) approved
Illinois 535 days 2026-01-16
The petitioner proposes to continue research in clinical pharmaceutical sciences, specifically focusing on understanding cancer development at the molecular level. The work involves investigating mechanisms such as genome instability and replication stress to identify actionable molecular targets for cost-conscious therapeutic strategies.
View Case

Postdoctoral Researcher

Research and Development · South Korea

WeGreened EB-2 (NIW) approved
California 174 days 2022-09-29
The petitioner proposes to continue identifying lead molecules to develop novel drugs for treating cancer, autoimmune diseases, addiction, neurodegenerative diseases, and viral infections. The work specifically focuses on translesion synthesis to support the development of targeted therapeutics that circumvent drug resistance in cancer patients.
View Case

Physician

Biotechnology · China

WeGreened EB-2 (NIW) approved
27 days 2025-03-13
The petitioner proposes to focus on repurposing existing drugs for cancer treatment by leveraging advanced computational methods and bioinformatics tools. This work aims to enhance therapeutic options, improve patient outcomes, and significantly reduce the time and cost associated with traditional drug development.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Research and Development cases More cases from Hong Kong

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-04-23.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 80 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Hong Kong All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist